WDAY Stock Analysis: Workday | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 49.868m USD | 12M Return: -15.3% | US98138H1014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 860M
EPS Trend: 99.7%
Qual. Beats: 14
Rev. Trend: 99.8%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Workday, Inc. is a U.S.-based provider of enterprise cloud applications sold primarily through a direct sales force, serving customers across professional services, financial services, healthcare, manufacturing, media, education, government, technology, retail, and hospitality. Its product suite centers on financial management (accounting, payables/receivables, consolidation, and audit controls), human capital management (hiring, onboarding, payroll, and employee development), spend and expense management, enterprise planning, and industry-specific extensions such as healthcare supply chain and education student lifecycle solutions. The company also offers Workday Extend, allowing customers and developers to build custom applications on its platform.
The business operates on a subscription-based software-as-a-service (SaaS) model, generating recurring revenue by licensing its cloud applications to large organizations. Headquartered in Pleasanton, California, Workday was incorporated in 2005 (formerly North Tahoe Power Tools, Inc.) and is listed on NASDAQ under the ticker WDAY within the Application Software sub-industry of the Information Technology sector. Its target customer base consists of medium-to-large enterprises that centralize finance, HR, and planning functions on a unified cloud platform.
- Subscription revenue growth beats consensus on enterprise demand
- Oracle and SAP competition intensifies in cloud HCM market
- AI product innovation drives new customer wins and contract sizes
| Net Income: 1.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 4.62 > 1.0 |
| NWC/Revenue: -5.95% < 20% (prev 57.86%; Δ -63.81% < -1%) |
| CFO/TA 0.19 > 3% & CFO 3.08b > Net Income 1.25b |
| Net Debt (1.19b) to EBITDA (1.67b): 0.71 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.2m) vs 12m ago -7.38% < -2% |
| Gross Margin: 75.80% > 18% (prev 75.58%; Δ 0.22% > 0.5%) |
| Asset Turnover: 60.07% > 50% (prev 49.88%; Δ 10.19% > 0%) |
| Interest Coverage Ratio: 11.74 > 6 (EBIT TTM 1.30b / Interest Expense TTM 111.0m) |
| A: -0.04 (Total Current Assets 5.97b - Total Current Liabilities 6.57b) / Total Assets 15.9b |
| B: 0.02 (Retained Earnings 342.0m / Total Assets 15.9b) |
| C: 0.08 (EBIT TTM 1.30b / Avg Total Assets 16.9b) |
| D: 0.69 (Book Value of Equity 6.46b / Total Liabilities 9.40b) |
| Altman-Z'' = 1.06 = BB |
| DSRI: 1.01 (Receivables 1.92b/1.67b, Revenue 10.2b/8.96b) |
| GMI: 1.00 (GM 75.58% / 75.80%) |
| AQI: 1.53 (AQ_t 0.51 / AQ_t-1 0.33) |
| SGI: 1.13 (Revenue 10.2b / 8.96b) |
| TATA: -0.12 (NI 1.25b - CFO 3.08b) / TA 15.9b) |
| Beneish M = -2.62 (Cap -4..+1) = A |
As of September 06, 2026, the stock is trading at USD 195.79 with a total of 2,864,986 shares traded. Over the past week, the price has changed by -4.36%, over one month by +14.31%, over three months by +32.37% and over the past year by -15.29%.
Current recommended Stop Loss: 178.60 (which is 8.8% or 1.7 ATR below the current price).
Workday has received a consensus analysts rating of 4.05. Therefore, it is recommended to buy WDAY.
- StrongBuy: 18
- Buy: 7
- Hold: 16
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 207.1 | 5.8% |
P/E Trailing = 42.2286
P/E Forward = 18.2482
P/S = 4.9107
P/B = 7.4009
P/EG = 0.725
Revenue TTM = 10.2b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 2.99b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.13b USD (from shortTermDebt, last quarter)
Debt = 4.59b USD (from shortLongTermDebtTotal, last quarter) + Leases 817.0m
Net Debt = 1.19b USD (calculated: Debt 4.59b - CCE 3.40b)
Enterprise Value = 51.1b USD (49.9b + Debt 4.59b - CCE 3.40b)
Interest Coverage Ratio = 11.74 (Ebit TTM 1.30b / Interest Expense TTM 111.0m)
EV/FCF = 17.95x (Enterprise Value 51.1b / FCF TTM 2.84b)
FCF Yield = 5.57% (FCF TTM 2.84b / Enterprise Value 51.1b)
FCF Margin = 28.00% (FCF TTM 2.84b / Revenue TTM 10.2b)
Net Margin = 12.32% (Net Income TTM 1.25b / Revenue TTM 10.2b)
Gross Margin = 75.80% ((Revenue TTM 10.2b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 75.41% (prev 76.24%)
Tobins Q-Ratio = 3.22 (Enterprise Value 51.1b / Total Assets 15.9b)
Interest Expense / Debt = 2.42% (Interest Expense 111.0m / Debt 4.59b)
Taxrate = 2.57% (33.0m / 1.28b)
NOPAT = 1.27b (EBIT 1.30b * (1 - 2.57%))
Current Ratio = 0.91 (Total Current Assets 5.97b / Total Current Liabilities 6.57b)
Debt / Equity = 0.71 (Debt 4.59b / totalStockholderEquity, last quarter 6.46b)
Debt / EBITDA = 0.71 (Net Debt 1.19b / EBITDA 1.67b)
Debt / FCF = 0.42 (Net Debt 1.19b / FCF TTM 2.84b)
Total Stockholder Equity = 7.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 1.25b / Total Assets 15.9b)
RoE = 16.78% (Net Income TTM 1.25b / Total Stockholder Equity 7.46b)
RoCE = 12.48% (EBIT 1.30b / Capital Employed (Equity 7.46b + L.T.Debt 2.99b))
RoIC = 12.82% (NOPAT 1.27b / Invested Capital 9.91b)
WACC = 6.99% (E(49.9b)/V(54.5b) * Re(7.42%) + D(4.59b)/V(54.5b) * Rd(2.42%) * (1-Tc(0.03)))
Discount Rate = 7.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -75.78 | Cagr: -3.37%
[DCF] Terminal Value 77.97% ; FCFF base≈2.66b ; Y1≈3.05b ; Y5≈4.49b
[DCF] Fair Price = 338.9 (EV 67.6b - Net Debt 1.19b = Equity 66.4b / Shares 196.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.66 | EPS CAGR: 25.59% | SUE: 4.0 | # QB: 14
Revenue Correlation: 99.82 | Revenue CAGR: 14.47% | SUE: 1.74 | # QB: 4
EPS current Quarter (2026-10-31): EPS=2.73 | Chg30d=+3.54% | Revisions=+25% | Analysts=35
EPS current Year (2027-01-31): EPS=11.06 | Chg30d=+2.80% | Revisions=+40% | GrowthEPS=+19.9% | GrowthRev=+11.7%
EPS next Year (2028-01-31): EPS=13.21 | Chg30d=+4.50% | Revisions=+0% | GrowthEPS=+19.4% | GrowthRev=+10.5%
[Analyst] Revisions Ratio: +38% (up=4, down=1)